🔴 Immunic, Inc. is trading 10.3% down today as rising Treasury yields pressure growth and biotech stocks

Immunic, Inc. is trading 10.3% down at $12.95 amid a broad risk-off move following stronger-than-expected U.S. jobs data.

• The robust labor market report has pushed Treasury yields and interest rate expectations higher, weighing heavily on growth-sensitive and biotech names.
• Shares are declining alongside major indices with no company-specific news, as investors reprice assets for a potentially longer period of restrictive Federal Reserve policy.